Gabazine
Gabazine[edit]
Gabazine, also known as SR-95531, is a potent GABA_A receptor antagonist. It is primarily used in neuroscience research to study the role of GABAergic inhibition in the central nervous system. Gabazine is a competitive antagonist that binds to the GABA binding site on the GABA_A receptor, thereby inhibiting the action of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the brain.
Mechanism of Action[edit]
Gabazine functions by blocking the GABA_A receptor, which is a ligand-gated ion channel that mediates inhibitory synaptic transmission in the central nervous system. When GABA binds to the GABA_A receptor, it typically causes the channel to open, allowing chloride ions to flow into the neuron, leading to hyperpolarization and inhibition of neuronal firing. Gabazine competes with GABA for binding to the receptor, preventing the opening of the chloride channel and thus reducing inhibitory synaptic transmission.
Applications in Research[edit]
Gabazine is widely used in neuroscience research to investigate the role of GABAergic inhibition in various physiological and pathological processes. By blocking GABA_A receptors, researchers can study the effects of reduced inhibition on neuronal circuits, synaptic plasticity, and neural network activity. Gabazine is also used to explore the mechanisms underlying epilepsy, anxiety, and other neurological disorders where GABAergic signaling is disrupted.
Pharmacology[edit]
Gabazine is a selective antagonist for the GABA_A receptor and does not significantly affect other types of GABA receptors, such as GABA_B receptors. Its selectivity makes it a valuable tool for dissecting the specific contributions of GABA_A receptor-mediated inhibition in various experimental models.
Safety and Handling[edit]
As with many research chemicals, gabazine should be handled with care. It is important to follow appropriate safety protocols, including the use of personal protective equipment and proper disposal methods, to minimize exposure and environmental impact.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
